Dentsply Sirona

Dentsply Sirona to Participate in Upcoming Investor Conferences

Retrieved on: 
Mercoledì, Maggio 8, 2024
Jaws, Sirona, Bank, Dentsply Sirona, Conference, XRAY, Bank of America, The Company

CHARLOTTE, N.C., May 08, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.

Key Points: 
  • CHARLOTTE, N.C., May 08, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.
  • Bank of America 2024 Health Care Conference on May 15, 2024, at 9:20 am PT (12:20 pm ET)
    Stifel 2024 Jaws and Paws Conference on May 29, 2024, at 12:40 pm ET
    Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com.

Global Tax Management Bolsters its Utility Tax Practice with New Director Nicole McKinney

Retrieved on: 
Giovedì, Maggio 9, 2024
Finance, Consulting, Banking, Accounting, Professional Services, Nikki, International, UGI, GTM, Culture, McKinney, Texas, UGI Corporation, Villanova University, Multimedia, Dentsply Sirona, Certified Public Accountant, Metro, Growth, Property management

Global Tax Management (GTM), a corporate tax services firm dedicated to helping mid-size and large multinational corporations address complex tax operations, announced today that Nicole “Nikki” McKinney has joined as a Director in the firm’s Lead Tax Practice, based in the firm’s Philadelphia Metro office.

Key Points: 
  • Global Tax Management (GTM), a corporate tax services firm dedicated to helping mid-size and large multinational corporations address complex tax operations, announced today that Nicole “Nikki” McKinney has joined as a Director in the firm’s Lead Tax Practice, based in the firm’s Philadelphia Metro office.
  • View the full release here: https://www.businesswire.com/news/home/20240506332988/en/
    Prior to joining GTM, Nikki oversaw regulatory tax and accounting at UGI Utilities in Pennsylvania for nearly a decade.
  • In addition to her utility tax work, Nikki has worked in the accounting and tax departments of multiple small to mid-sized businesses.
  • Most recently, she served as the managing director of a professional services management firm, overseeing financial and operational aspects.

A New Era of Growth: 2024 GAC International Global Distributor Conference

Retrieved on: 
Mercoledì, Aprile 24, 2024
GAC, Yoy, Conference, Dentsply Sirona, Optimism, Marketing, GAC Group, Growth, Strategic planning, Environmental remediation

GUANGZHOU, China, April 24, 2024 /PRNewswire/ -- GAC has wrapped up its 2024 International Global Distributor Conference with resounding success.

Key Points: 
  • GUANGZHOU, China, April 24, 2024 /PRNewswire/ -- GAC has wrapped up its 2024 International Global Distributor Conference with resounding success.
  • GAC GROUP achieved record-breaking production and sales exceeding 2.5 million units in 2023, a milestone for Chinese independent brands.
  • With a remarkable YoY export surge of approximately 130% and strategic penetration into 39 countries and regions, GAC International has laid a robust groundwork for future growth ambitions.
  • The 2024 GAC International Distributor Conference is a reflection of the many enduring partnerships forged amidst the pursuit of excellence.

A New Era of Growth: 2024 GAC International Global Distributor Conference

Retrieved on: 
Mercoledì, Aprile 24, 2024
GAC, Yoy, Conference, Dentsply Sirona, Optimism, Multimedia, Marketing, GAC Group, Growth, Strategic planning, Environmental remediation

GUANGZHOU, China, April 24, 2024 /PRNewswire/ -- GAC has wrapped up its 2024 International Global Distributor Conference with resounding success.

Key Points: 
  • GUANGZHOU, China, April 24, 2024 /PRNewswire/ -- GAC has wrapped up its 2024 International Global Distributor Conference with resounding success.
  • GAC GROUP achieved record-breaking production and sales exceeding 2.5 million units in 2023, a milestone for Chinese independent brands.
  • With a remarkable YoY export surge of approximately 130% and strategic penetration into 39 countries and regions, GAC International has laid a robust groundwork for future growth ambitions.
  • The 2024 GAC International Distributor Conference is a reflection of the many enduring partnerships forged amidst the pursuit of excellence.

Politan Nominates Two Independent Candidates for Masimo Board

Retrieved on: 
Lunedì, Marzo 25, 2024
Banking, Professional Services, Finance, Analytical chemistry, Biophysical environment, Health, Lead, Doctor of Philosophy, IP, M&A, Audit committee, Corporate spin-off, Audit, WHEN, WILL, Science, MASI, Stryker Corporation, Laboratory, Dentsply Sirona, Compensated emancipation, Common stock, Financial management, Knowledge, Broadcom Inc., Acquisition, Security (finance), Senior, INC, Avient Corporation, Annual general meeting, Separation, WALL, MIT, Common, Hope College, Stanford University, National academy, Government, COGS, Management

Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), today announced that it is nominating two candidates for election to the Masimo Board of Directors (the “Board”) at the upcoming 2024 Annual Meeting of Stockholders (the “Annual Meeting”).

Key Points: 
  • Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), today announced that it is nominating two candidates for election to the Masimo Board of Directors (the “Board”) at the upcoming 2024 Annual Meeting of Stockholders (the “Annual Meeting”).
  • Quentin Koffey, Managing Partner and Chief Investment Officer of Politan, and a current director on the Masimo Board, stated:
    “When shareholders overwhelmingly elected Michelle Brennan and me to the Masimo Board last year, we were optimistic we could work productively with the rest of the Board to drive positive change.
  • However, at this stage the Board has been provided zero details, and Politan has serious concerns given the lack of basic governance and oversight we have observed since joining the Board.
  • The participants in the proxy solicitation are Politan, Politan Capital Management GP LLC, Politan Capital Partners GP LLC, Politan Capital NY LLC, Politan Intermediate Ltd., Politan Capital Partners Master Fund LP (“Politan Master Fund”), Politan Capital Partners LP (“Politan LP”), Politan Capital Offshore Partners LP (“Politan Offshore” and collectively with Politan Master Fund and Politan LP, the “Politan Funds”), Quentin Koffey, Matthew Hall, Aaron Kapito, William Jellison and Darlene Solomon (collectively, the “Participants”).

Spectro Cloud Marks Award-Winning Year of Innovation in Kubernetes

Retrieved on: 
Mercoledì, Febbraio 21, 2024
Data Management, Security, Technology, Networks, Artificial Intelligence, Internet, Hardware, Cloud, Stellar, Intel, CRN, Multimedia, Tevel, T-Mobile, MSP, Dentsply Sirona, Secure, Channel, CDW, Government, Public sector, Partner, United States Air Force, Ecosystem, FIPS, Instrument, GE HealthCare, Heart, Environment, AWS, Partnership, Video game

View the full release here: https://www.businesswire.com/news/home/20240219675527/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240219675527/en/
    Partner CDW Digital Velocity has seen Spectro Cloud's innovation and market momentum accelerate.
  • Jim Melton, Head of Cloud Strategic Alliances and Programs, notes that Spectro Cloud truly understands enterprise Kubernetes requirements.
  • Spectro Cloud has racked up a dozen awards in the past year, including Cloud 100, Stellar Startup, Tech Innovator and Channel Chief rankings with CRN.
  • We’re excited to explore how this new program will help us accelerate together with Spectro Cloud.”
    The Spectro Cloud Partner Program is effective immediately, accessible from “Partner Mission Control”, Spectro Cloud’s new partner portal.

Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2023 Results

Retrieved on: 
Martedì, Gennaio 9, 2024
Annual report, Sirona, Exhibit, GAAP, EPS, Conference, Webcast, Dentsply Sirona, XRAY, Orthodontics, The Company, Growth, Cryptocurrency

CHARLOTTE, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET).

Key Points: 
  • CHARLOTTE, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET).
  • As part of the conference, the Company is providing an update on its 2023 full year anticipated financial results, with net sales expected to be at or above the high end of the Company’s previously provided outlook range of $3.90 billion to $3.94 billion.
  • The Company is reaffirming its full year 2023 adjusted EPS outlook range of $1.80 to $1.85 and its expectations for double-digit adjusted EPS growth in 2024.
  • The preliminary estimates above are based solely upon information available to management as of the date of this press release and are subject to change.

Dentsply Sirona to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Mercoledì, Gennaio 3, 2024
Conference, Dentsply Sirona, The Company, XRAY, Sirona

Charlotte, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference.

Key Points: 
  • Charlotte, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference.
  • Management is scheduled to present on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET).
  • Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com.

BioMarin Announces Governance Enhancements and Value Creation Initiatives

Retrieved on: 
Mercoledì, Dicembre 20, 2023
Adverum Biotechnologies, University, Ambit Biosciences, Daiichi Sankyo, Hill-Rom, Indiana University, Harvard Law School, Baxter, Acceleration, Strategy, Palmer, Pfizer, Biotechnology Innovation Organization, Invacare, Eli Lilly, Hospira, Pediatrics, Chairperson, The Nature Conservancy, Genzyme, American Cancer Society, Therapy, Goldman Sachs, M.B.A, BMRN, ImmunoGen, DSM-IV codes, Shire (pharmaceutical company), IPO, Patient, Proteostasis, BioMarin Pharmaceutical, Corporate development, Dentsply Sirona, Senior, Syneos Health, Iovance Biotherapeutics, Sclerosis, Acquisition, SAN, CIO, Eli Lilly and Company, Interim, Bristol Myers Squibb, Information technology, Management

SAN RAFAEL, Calif., Dec. 20, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today announced several initiatives to enhance corporate governance and long-term shareholder value creation.

Key Points: 
  • SAN RAFAEL, Calif., Dec. 20, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today announced several initiatives to enhance corporate governance and long-term shareholder value creation.
  • "Today's announcements will strengthen our ability to drive better outcomes for patients with genetic diseases and deliver value to all stakeholders.
  • BioMarin plays a pivotal role in the treatment of genetic diseases thanks to its globally leading rare-disease portfolio.
  • We believe the changes announced today put BioMarin in the best position to realize its full potential, and we support Alexander Hardy as the right leader for this chapter of BioMarin's value creation story.

Dentsply Sirona to Participate in Upcoming Investor Conferences

Retrieved on: 
Venerdì, Novembre 10, 2023
The Company, XRAY, Dentsply Sirona, Conference, Sirona

CHARLOTTE, N.C., Nov. 10, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.

Key Points: 
  • CHARLOTTE, N.C., Nov. 10, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.
  • Jefferies 2023 London Healthcare Conference on November 15, 2023, at 8:30 am GMT
    6th Annual Evercore ISI HealthCONx Conference on November 29, 2023, at 8:00 am ET
    Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com.